ACTA1 and benign prostatic hyperplasia: RG treatment significantly decreased the expression of α-SMA in BPH-1 cells and decreased the expression of α-SMA, increased the expression of E-cad and ZO-1 in RWPE-1 cells which indicated that RG could suppress the progression of EMT (Fig. 5C–D).